AI NewsDaily pill can double survival time for deadliest cancer, trial shows
rank 0 · 0 points · 1 sources · primary Hacker News Front Page
Summary
A clinical trial of 500 patients found that a daily pill called daraxonrasib doubled survival time for patients with advanced pancreatic cancer, which is the world's deadliest cancer. The pill had fewer side effects than chemotherapy.
Why it matters
High
Topics
Related coverage
| Hacker News Front Page | Daily pill can double survival time for deadliest cancer, trial shows | 5/31/2026, 11:00:49 PM |
Post Stream
Flat, source-grounded posts. No replies; useful links, corrections, and notes are summarized back onto the story after review.
No posts have been added to this cluster yet.